Zaremba Rabourn Amy 4
4 · Opus Genetics, Inc. · Filed Apr 27, 2026
Research Summary
AI-generated summary of this filing
Opus Genetics (IRD) Head of Financial QA Amy Zaremba Rabourn Sells Shares
What Happened
Amy Zaremba Rabourn, Head of Financial Quality Assurance at Opus Genetics (IRD), disposed of 1,641 shares on April 23, 2026. The shares were sold at a weighted average price of $5.20 per share for total proceeds of approximately $8,540. The filing clarifies this was an automatic sale to satisfy tax withholding obligations arising from a restricted stock unit (RSU) vesting and settlement event, not a discretionary trade by the insider.
Key Details
- Transaction date: 2026-04-23; Form 4 filed 2026-04-27 (appears timely within the two-business-day filing window).
- Sale type/code: S (sale); Reason: automatic tax withholding related to RSU vesting (footnote F1).
- Price details: weighted average $5.20; shares sold in multiple trades at prices between $5.2038 and $5.2051 (footnote F2). The reporting person can provide a per-trade breakdown on request.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Filing accession: 0000905148-26-001865; Period of report: 2026-04-23.
Context
This was a tax-withholding sale tied to RSU settlement (routine), which typically does not indicate the insider’s view on the company’s prospects. The transaction value is relatively small (~$8.5k), so it’s unlikely to be materially informative about insider sentiment.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-04-23$5.20/sh−1,641$8,540→ 188,671 total
Footnotes (2)
- [F1]The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.
- [F2]The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.2038 to $5.2051, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.